The New Third Board listed company realized a total of 60.621 billion yuan in net profit in 2021

Author:Xinhua News Agency Time:2022.06.21

On June 20, the national small and medium -sized enterprise shares transfer system (New Third Board) listed companies in 2021 operated the "transcript". According to data from national stock transfer companies, in 2021, the new third board listed company realized operating income of 1.46 trillion yuan, an increase of 17.31%year -on -year; net profit was 60.621 billion yuan, an increase of 14.74%year -on -year.

The picture shows a biotechnology small and medium -sized enterprise employees working on the production line. Xinhua News Agency reporter Mu Yu

In 2021, the New Third Board Corporation invested net cash expenditure and financing cash inflows by 18.73%and 9.02%year -on -year, respectively. A total of 49.21 billion yuan in R & D expenditure throughout the year, an increase of 15.69%year -on -year.

The quality of the new listing company of the New Third Board has gradually improved. Data show that from the beginning of 2021 to the end of May 2022, the net profit of the newly listed 130 companies was 11.8914 million yuan, the net asset yield was 14.13%, and the performance exceeded the average.

According to statistics from the national stock transfer company, as of the end of May this year, a total of 416 new third board listed companies have disclosed the preparations for the preparations; 1,550 New Third Board companies have disclosed the dividend plan, of which the total cash dividend is 23.333 billion yuan. (Reporter Yao Junfang)

[Editor in charge: Qiu Lifang]

- END -

There are new changes in social security, what you want to ask is here-

With the release of the latest social security premium policy on June 2, the indus...

Xinjiang public medical institution new crown virus nucleic acid testing single -person single exami

Tianshan News (Reporter Ren Chunxiang reported) From June 10, the autonomous region has adjusted the price of new crown virus nucleic acid detection and antigen detection prices in the autonomous regi